Dozens of breakthrough drug trials, including one using the main ingredient in weight-loss jabs, offer patients “hope” for the treatment and prevention of dementia and Alzheimer’s disease.
Some 138 treatments are being assessed in clinical trials in 2025 - an 11 per cent rise on the year before - according to new research published on Tuesday.